NCT06855043View on ClinicalTrials.gov

Little Lungs Study

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2026

Primary Completion Date

January 31, 2028

Study Completion Date

January 31, 2028

Conditions
Invasive Mechanical VentilationSevere Respiratory Distress Syndrome
Interventions
DRUG

Calfactant

Participants will receive 3 daily doses of Calfactant (1.5ml/kg) administered intratracheally

DRUG

Budesonide

Participants will receive 3 daily doses of Budesonide (0.25mg/kg) administered intratracheally.

Trial Locations (2)

53715

Meriter Hospital, Madison

53792

American Family Children's Hospital, Madison

Sponsors

Collaborators (1)

Meriter Foundation
All Listed Sponsors
collaborator

Meriter Foundation

OTHER

lead

University of Wisconsin, Madison

OTHER